Literature DB >> 11231576

A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation.

S Selvarajan1, L R Lund, T Takeuchi, C S Craik, Z Werb.   

Abstract

Here we show that plasma kallikrein (PKal) mediates a plasminogen (Plg) cascade in adipocyte differentiation. Ecotin, an inhibitor of serine proteases, inhibits cell-shape change, adipocyte-specific gene expression, and lipid accumulation during adipogenesis in culture. Deficiency of Plg, but not of urokinase or tissue-type plasminogen activator, suppresses adipogenesis during differentiation of 3T3-L1 cells and mammary-gland involution. PKal, which is inhibited by ecotin, is required for adipose conversion, Plg activation and 3T3-L1 differentiation. Human plasma lacking PKal does not support differentiation of 3T3-L1 cells. PKal is therefore a physiological regulator that acts in the Plg cascade during adipogenesis. We propose that the Plg cascade fosters adipocyte differentiation by degradation of the fibronectin-rich preadipocyte stromal matrix.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231576      PMCID: PMC2802462          DOI: 10.1038/35060059

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  51 in total

1.  Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.

Authors:  J P Loza; V Gurewich; M Johnstone; R Pannell
Journal:  Thromb Haemost       Date:  1994-03       Impact factor: 5.249

2.  Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.

Authors:  Z Cao; R M Umek; S L McKnight
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

3.  Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation.

Authors:  D S Finbloom; E F Petricoin; R H Hackett; M David; G M Feldman; K Igarashi; E Fibach; M J Weber; M O Thorner; C M Silva
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

4.  TGF beta 1 prevents the down-regulation of type I procollagen, fibronectin, and TGF beta 1 gene expression associated with 3T3-L1 pre-adipocyte differentiation.

Authors:  R Bortell; T A Owen; R Ignotz; G S Stein; J L Stein
Journal:  J Cell Biochem       Date:  1994-02       Impact factor: 4.429

5.  Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O.

Authors:  J L Ramírez-Zacarías; F Castro-Muñozledo; W Kuri-Harcuch
Journal:  Histochemistry       Date:  1992-07

6.  Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases.

Authors:  C H Chung; H E Ives; S Almeda; A L Goldberg
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

7.  The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.

Authors:  N Behrendt; M Ploug; L Patthy; G Houen; F Blasi; K Danø
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

Review 8.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

9.  Physiological consequences of loss of plasminogen activator gene function in mice.

Authors:  P Carmeliet; L Schoonjans; L Kieckens; B Ream; J Degen; R Bronson; R De Vos; J J van den Oord; D Collen; R C Mulligan
Journal:  Nature       Date:  1994-03-31       Impact factor: 49.962

10.  Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture.

Authors:  R S Talhouk; J R Chin; E N Unemori; Z Werb; M J Bissell
Journal:  Development       Date:  1991-06       Impact factor: 6.868

View more
  51 in total

1.  Metalloproteases and adipogenesis: a weighty subject.

Authors:  Jennifer Lilla; Dominique Stickens; Zena Werb
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

2.  Pref-1 interacts with fibronectin to inhibit adipocyte differentiation.

Authors:  Yuhui Wang; Ling Zhao; Cynthia Smas; Hei Sook Sul
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

3.  Plasma kallikrein and diabetic macular edema.

Authors:  Edward P Feener
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

Review 4.  ECM roles in the function of metabolic tissues.

Authors:  Guorui Huang; Daniel S Greenspan
Journal:  Trends Endocrinol Metab       Date:  2011-11-08       Impact factor: 12.015

Review 5.  Apoptosis regulation in the mammary gland.

Authors:  K A Green; C H Streuli
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

6.  Adipose stromal-vascular fraction-derived paracrine factors regulate adipogenesis.

Authors:  Minyan Liu; Lei Guo; Yu Liu; Yu Pei; Nan Li; Mengmeng Jin; Lichao Ma; Zhibing Li; Banruo Sun; Chunlin Li
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

7.  Proteomic identification of novel plasma kallikrein substrates in the astrocyte secretome.

Authors:  Jia Liu; Ben-Bo Gao; Edward P Feener
Journal:  Transl Stroke Res       Date:  2010-08-28       Impact factor: 6.829

8.  Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.

Authors:  Martin O Judex; Barbara M Mueller
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution.

Authors:  Jennifer N Lilla; Ravi V Joshi; Charles S Craik; Zena Werb
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

10.  SPARC functions as an inhibitor of adipogenesis.

Authors:  Jing Nie; E Helene Sage
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.